EP2453926 - PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 08.07.2016 Database last updated on 30.10.2024 | Most recent event Tooltip | 08.07.2016 | Application deemed to be withdrawn | published on 10.08.2016 [2016/32] | Applicant(s) | For all designated states The Regents of the University of California 1111 Franklin Street, 12th Floor Oakland, CA 94607 / US | [N/P] |
Former [2012/21] | For all designated states The Regents of the University of California 1111 Franklin Street, 12th Floor Oakland, CA 94607 / US | Inventor(s) | 01 /
TSIEN, Roger 2665 Idle Hour Lane La Jolla California 92037 / US | 02 /
OLSON, Emilia 1416 Boylston Avenue Apt. 502 Seattle Washington 98122 / US | 03 /
JIANG, Tao 10637 Gingerwood Court San Diego California 92130 / US | 04 /
NGUYEN, Quyen 14094 Rue Saint Raphael Del Mar California 92014 / US | 05 /
WHITNEY, Mike 5171 Frink Avenue San Diego California 92117 / US | [2012/21] | Representative(s) | Campbell, Patrick John Henry J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | [2012/21] | Application number, filing date | 10800571.1 | 15.07.2010 | WO2010US42188 | Priority number, date | US20090225872P | 15.07.2009 Original published format: US 225872 P | [2012/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2011008996 | Date: | 20.01.2011 | Language: | EN | [2011/03] | Type: | A2 Application without search report | No.: | EP2453926 | Date: | 23.05.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.01.2011 takes the place of the publication of the European patent application. | [2012/21] | Search report(s) | International search report - published on: | KR | 26.05.2011 | (Supplementary) European search report - dispatched on: | EP | 15.07.2015 | Classification | IPC: | C07K7/06, C07K7/08, G01N33/52, G01N33/68, A61K47/42, A61K49/00, A61K47/48 | [2015/33] | CPC: |
A61K49/0032 (EP,US);
A61K47/64 (US);
A61K47/595 (EP,US);
A61K47/60 (EP,US);
A61K47/62 (EP,US);
A61K47/6911 (EP,US);
A61K49/0056 (EP,US);
A61P35/00 (EP);
A61P9/00 (EP);
C07K7/06 (EP,US)
(-)
|
Former IPC [2012/21] | A61K49/14, G01N33/52, G01N33/68, C07K7/08, A61K38/10, A61P9/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/21] | Title | German: | PEPTIDE MIT STEUERBARER ZELLULÄRER AUFNAHME | [2012/21] | English: | PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE | [2012/21] | French: | PEPTIDES DONT L ABSORPTION PAR LES CELLULES PEUT ÊTRE RÉGULÉE | [2012/21] | Entry into regional phase | 14.02.2012 | National basic fee paid | 14.02.2012 | Search fee paid | 14.02.2012 | Designation fee(s) paid | 14.02.2012 | Examination fee paid | Examination procedure | 14.02.2012 | Examination requested [2012/21] | 17.09.2012 | Amendment by applicant (claims and/or description) | 11.02.2016 | Application deemed to be withdrawn, date of legal effect [2016/32] | 18.03.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/32] | Fees paid | Renewal fee | 25.07.2012 | Renewal fee patent year 03 | 29.07.2013 | Renewal fee patent year 04 | 28.07.2014 | Renewal fee patent year 05 | 27.07.2015 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2005042034 (UNIV CALIFORNIA [US], et al) [A] 1-15 * abstract *; | [X]WO2006125134 (UNIV CALIFORNIA [US], et al) [X] 1-5,7-15 * abstract * * page 6, paragraph 18 - paragraph 19; table 1 * * page 38, paragraph 167 * * page 63, paragraph 224; examples 19,20,22,23,27,32 * * claims 21-27 *; | [X] - E.S. Olson, "Activatable Cell Penetrating Peptides for Imaging Protease Activity In Vivo", University of California, San Diego, (2008), pages FP-xvii,1 - 152, URL: https://escholarship.org/uc/item/3sc4h3n7#page-1, (20150703), XP002741765 [X] 1-15 * page 65 - page 133 * | [X] - OLSON EMILIA S ET AL, "In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer", INTEGRATIVE BIOLOGY, RSC PUBLISHING, (20090601), vol. 1, no. 5-6, ISSN 1093-4391, pages 382 - 393, XP009163754 [X] 1-5,7-10,12-15 * whole document, in particular page 388, left-hand column, paragraph 2 to page 389, left-hand column, paragraph 1; Fig.6 * DOI: http://dx.doi.org/10.1039/b904890a | [X] - JIANG T ET AL, "Tumor imaging by means of proteolytic activation of cell-penetrating peptides", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (20041221), vol. 101, no. 51, doi:10.1073/PNAS.0408191101, ISSN 0027-8424, pages 17867 - 17872, XP002369426 [X] 1-5,7-10,12-15 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.0408191101 | [A] - AGUILERA TODD A ET AL, "Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides", INTEGRATIVE BIOLOGY, ROYAL SOCIETY OF CHEMISTRY, UK, vol. 1, no. 5-6, doi:10.1039/B904878B, ISSN 1757-9694, (20090601), pages 371 - 381, (20090511), XP009163753 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1039/B904878B | International search | [A]US5910300 (TOURNIER HERVE [FR], et al); | [A]US2001021763 (HARRIS J MILTON [US]); | [A]US2004009122 (KLAVENESS JO [NO], et al); | [A]US2004241096 (BOGDANOV ALEXEI [US], et al); | [A]US2005107583 (JIANG TAO [US], et al); | [A]US2009004118 (NIE SHUMING [US], et al) |